Clinical Trial Update: A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating a 14-day modified sequential therapy for Helicobacter pylori infection. Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN